The Street’s Key Stock Analysts Research Reports


FLASH: US Financial Markets are Closed Monday for President’s Day.

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Monday as follows:

American International Group Inc. (NYSE:AIG) was raised to Buy from Neutral and the target price was raised to 56 from 44 at Compass Point. AIG has a 52-wk trading range of 36.16 – 61.36 and a consensus target price of 51.43.

CareDx Inc. (NASDAQ:CDNA) was started with a Buy rating and assigned a 35 price target at Jefferies.

Harvard Bioscience Inc. (NASDAQ: HBIO): Analysts reiterated HBIO a Buy with an 8 price target at Janney, with the firm calling it the deepest value in small-cap life science tools with high earnings visibility and P/E multiples valued at about 50% of peer marks. The 52-wk trading range is 2.75 – 6.70.

Insmed Inc. (NASDAQ:INSM) was raised to Outperform from Market Perform at JMP Securities. The 52-wk trading range is 11.31 – 31.58 and the consensus target price is at 36.70.

Workday Inc. (NASDAQ:WDAY) was raised to Outperform from Market Perform and the target price was raised to 225 from 160 at Cowen. The shares trade a 52-wk range of 117.24 – 193.08 and a consensus target price of 163.86.

Have a terrific week.

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :